# Pharma Manufacturing Quality Implementation Status

Status: improve1 executable control slice complete for all 50 backlog features.

Evidence:
- `quality_control.py` maps feature 1-50 to owned pharma quality control tables, required fields, UI surfaces, service/API routes, declared event/API/projection dependencies, tests, and release evidence.
- Runtime exposes `quality_control` and the `evaluate_quality_control` operation.
- UI exposes 50 pharma quality control panels, service actions, and agent tool identifiers.
- Release evidence and validation include the pharma manufacturing quality improve1 control contract.
- `tests/test_domain_behavior.py` gates MBR versioning, EBR execution, lot genealogy, equipment qualification, CPP/IPC/EM monitoring, deviation/CAPA, change control, validation, CPV, cleaning, mix-up prevention, serialization, batch release, quarantine, stability, OOS/OOT, supplier quality, training, document control, data integrity, recall, inspections, tech transfer, packaging reconciliation, expiry, metrics, predictive risk, simulations, boundary proofs, e-signatures, audit, crypto proofs, dead letters, carbon/resource awareness, seed scenarios, permissions, localization, release simulation, overlap guardrails, and composition DSL exposure.

Constraints preserved:
- Allowed database backends remain PostgreSQL, MySQL, and MariaDB.
- Eventing uses the AppGen-X event contract and `pbc.pharma_manufacturing_quality.events` topic.
- Cross-PBC inputs are declared as APIs, events, or projections; shared table access remains rejected.
